Our Expertise & Capabilities

Eurocept Pharmaceuticals facilitates the relationship between healthcare professionals and patients.
We provide our partners with specialised capabilities, license-in services and solutions required to bring treatments to patients efficiently. Discover how our commercial expertise can support your goals.

Eurocept Pharmaceuticals facilitates the relationship between healthcare professionals and patients.
We provide our partners with specialised capabilities, license-in services and solutions required to bring treatments to patients efficiently. Discover how our commercial expertise can support your goals.

Expertise

Simplifying Healthcare as your dedicated One-Stop Shop

Simplifying Healthcare as your
dedicated One-Stop Shop

Pharmaceutical Development

Lucane Pharma has extensive expertise in developing medicines for small patient populations suffering from life-threatening diseases. We excel at overcoming complex formulation challenges, our specialized production capabilities are fully equiped for small-volume manufacturing, ensuring maximum batch efficiency and stable shelf life.

Clinical Development

Clinical trials for rare diseases face a unique challenge: small patient numbers make large-scale studies nearly impossible. Lucane Pharma overcomes this by designing specialized clinical programs tailored for small groups. We work closely with medical doctors to define clear, measurable clinical goals, ensuring new treatments are evaluated both safely and effectively.

Commercial

The Commercial team at Lucane Pharma supports partners in the management of hospital, insurer, and national tenders. The team provides end-to-end tender management, from opportunity identification and submission to post-tender evaluation, always keeping patient's interest at the forefront of our actions.

Regulatory Affairs & Quality

Lucane Pharma has extensive experience in obtaining and maintaining regulatory approvals for more than 100 products via CP, National, MRP, and DCP procedures. Lucane Pharma holds manufacturing and wholesale licences and is GMP- and GDP-certified by the Dutch Inspectorate, by the ANSM and the Turkish authorities. On request, the company supports EU batch release and artwork development, complaints and deviations handling, shortages and derogations and, where regulations allow, operates Named Patient Programs.

Pharmacovigilance

The pharmacovigilance department within Lucane Pharma manages a global PV system that complies with relevant country legislation and regulations world-wide. All aspect of pharmacovigilance, monitoring the benefit-risk profile of the medication and QPPV services are in-house handled responsibilities. In addition, the pharmacovigilance department can provide local pharmacovigilance services for distribution partners.

Market Access & P&R

The market access team provides comprehensive market access services, including obtaining and maintaining pricing and reimbursement. With experience across more than 180 products, the company has proven expertise in successfully navigating pricing and reimbursement procedures across a wide range of scenarios and stakeholder levels. This includes maintaining partner product records in relevant systems and implementing mandatory price updates resulting from European reference pricing.

We’re happy to assist you.

We’re happy to assist you.

At Lucane Pharma, we prioritize the patient, direct communication and operational speed. Contact us today to discuss your portfolio or global distribution opportunities.

Facilitating the therapeutic relationship between care providers and patients since 2001.

All rights reserved.

Copyright 2026 by Eurocept Pharmaceuticals Holding

P9007.00.148-okt2026

Facilitating the therapeutic relationship between care providers and patients since 2001.

All rights reserved.

Copyright 2026 by Eurocept Pharmaceuticals Holding

P9007.00.148-okt2026

Facilitating the therapeutic relationship between care providers and patients since 2001.

All rights reserved.

Copyright 2026 by Eurocept Pharmaceuticals Holding

P9007.00.148-okt2026